BidaskClub lowered shares of Castlight Health, inc. (NYSE:CSLT) from a hold rating to a sell rating in a research report sent to investors on Sunday, July 30th.

Several other analysts have also recently commented on the company. Zacks Investment Research upgraded Castlight Health, inc. from a sell rating to a hold rating in a report on Tuesday, June 27th. Chardan Capital assumed coverage on Castlight Health, inc. in a report on Tuesday, June 6th. They issued a buy rating and a $4.50 price target for the company. ValuEngine cut Castlight Health, inc. from a hold rating to a sell rating in a report on Friday, May 19th. Morgan Stanley lowered Castlight Health, inc. from an equal weight rating to an underweight rating and reduced their price objective for the company from $4.00 to $3.75 in a research note on Friday, May 12th. Finally, Dougherty & Co began coverage on Castlight Health, inc. in a research note on Wednesday, May 10th. They issued a buy rating and a $5.50 price objective on the stock. Three investment analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company’s stock. The stock presently has an average rating of Hold and a consensus target price of $4.57.

Castlight Health, inc. (CSLT) traded up 2.60% on Friday, reaching $3.95. 309,826 shares of the company’s stock were exchanged. The company’s market capitalization is $520.16 million. The company has a 50 day moving average price of $4.27 and a 200-day moving average price of $3.79. Castlight Health, inc. has a 1-year low of $3.05 and a 1-year high of $5.50.

Castlight Health, inc. (NYSE:CSLT) last posted its quarterly earnings results on Wednesday, August 2nd. The software maker reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.02. The company had revenue of $32.10 million during the quarter, compared to analysts’ expectations of $31.14 million. Castlight Health, inc. had a negative return on equity of 36.30% and a negative net margin of 42.54%. The firm’s revenue was up 36.0% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.11) EPS. On average, equities research analysts anticipate that Castlight Health, inc. will post ($0.25) earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Castlight Health, inc. (CSLT) Cut to “Sell” at BidaskClub” was first published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The correct version of this article can be read at https://theolympiareport.com/2017/08/12/castlight-health-inc-cslt-cut-to-sell-at-bidaskclub-updated.html.

In related news, insider Giovanni M. Colella sold 11,456 shares of the business’s stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $3.75, for a total transaction of $42,960.00. Following the transaction, the insider now directly owns 88,094 shares of the company’s stock, valued at approximately $330,352.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Priya Jain sold 7,858 shares of the business’s stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $3.65, for a total value of $28,681.70. Following the transaction, the chief accounting officer now directly owns 20,000 shares in the company, valued at $73,000. The disclosure for this sale can be found here. Insiders sold a total of 60,051 shares of company stock worth $233,723 over the last ninety days. Corporate insiders own 37.43% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in the company. Oxford Asset Management bought a new position in Castlight Health, inc. during the first quarter valued at approximately $102,000. Stifel Financial Corp raised its position in Castlight Health, inc. by 4.3% in the first quarter. Stifel Financial Corp now owns 36,500 shares of the software maker’s stock valued at $133,000 after buying an additional 1,500 shares during the period. Nationwide Fund Advisors raised its position in Castlight Health, inc. by 49.5% in the second quarter. Nationwide Fund Advisors now owns 36,418 shares of the software maker’s stock valued at $151,000 after buying an additional 12,061 shares during the period. FNY Partners Fund LP bought a new position in Castlight Health, inc. during the first quarter valued at approximately $164,000. Finally, Edge Wealth Management LLC bought a new position in Castlight Health, inc. during the first quarter valued at approximately $172,000. 39.10% of the stock is currently owned by hedge funds and other institutional investors.

About Castlight Health, inc.

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Analyst Recommendations for Castlight Health, inc. (NYSE:CSLT)

Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.